Latest Breaking News On - Financing prudence - Page 1 : comparemela.com

MIAMI, April 08, 2024 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicin.

United statesDerek coleExchange commissionLongeveron incExchange commission onDrug administrationAdvocacy group partnershipWa el hashadHypoplastic left heart syndromeRare pediatric diseaseOrphan drugFast trackCore business objectivesMain value driverManufacturing capabilitiesResource management